AU Stock MarketDetailed Quotes

Neuroscientific Biopharmaceuticals Ltd (NSB)

Watchlist
  • 0.115
  • 0.0000.00%
20min DelayNot Open Apr 24 15:14 AET
38.25MMarket Cap-8.85P/E (Static)

Neuroscientific Biopharmaceuticals Ltd (NSB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Operating cash flow (direct method)
Cash income from operating activities
-10.69%4.42M
4.95M
2,411.67%1.02M
19.77%40.54K
33.85K
Revenue from customers
----
-55.34%2.21M
--4.95M
----
2,411.67%1.02M
19.77%40.54K
--33.85K
Income from government grants
----
--2.21M
----
----
----
----
----
Cash paid
51.12%-1.13M
68.74%-2.3M
-5.05%-7.36M
-92.21%-7.01M
-54.94%-3.65M
-54.24%-2.35M
-1.53M
Payments to suppliers for goods and services
51.12%-1.13M
68.74%-2.3M
-5.05%-7.36M
-92.21%-7.01M
-54.94%-3.65M
-54.24%-2.35M
---1.53M
Direct interest paid
----
200.00%157
---157
----
98.16%-63
-634.84%-3.42K
---465
Direct interest received
36.90%183.92K
24.94%134.35K
57.09%107.53K
147.60%68.45K
-22.63%27.65K
-58.18%35.73K
--85.44K
Operating cash flow
-2,227.35%-941.33K
101.92%44.25K
66.81%-2.3M
-166.85%-6.94M
-14.04%-2.6M
-62.09%-2.28M
---1.41M
Investing cash flow
Cash flow from continuing investing activities
-1,885.90%-36.04K
-1.82K
87.06%-3.87K
-1,154.32%-29.88K
87.52%-2.38K
-19.08K
Net PPE purchase and sale
----
---1.82K
----
87.06%-3.87K
-1,154.32%-29.88K
87.52%-2.38K
---19.08K
Net business purchase and sale
---36.04K
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-1,885.90%-36.04K
---1.82K
----
87.06%-3.87K
-1,154.32%-29.88K
87.52%-2.38K
---19.08K
Financing cash flow
Cash flow from continuing financing activities
3.29M
0
1,305.79%13.51M
-83.80%960.8K
5.93M
Net common stock issuance
--3.29M
----
----
----
1,305.79%13.51M
-83.80%960.8K
--5.93M
Cash from discontinued financing activities
Financing cash flow
--3.29M
--0
----
----
1,305.79%13.51M
-83.80%960.8K
--5.93M
Net cash flow
Beginning cash position
0.86%4.95M
-31.93%4.91M
-49.05%7.22M
330.88%14.16M
-28.70%3.29M
4,336.85%4.61M
--103.9K
Current changes in cash
5,347.58%2.31M
101.84%42.43K
66.83%-2.3M
-163.87%-6.95M
922.14%10.88M
-129.36%-1.32M
--4.51M
End cash Position
46.66%7.27M
0.86%4.95M
-31.93%4.91M
-49.05%7.22M
330.88%14.16M
-28.70%3.29M
--4.61M
Free cash from
-2,318.34%-941.33K
101.84%42.43K
66.83%-2.3M
-163.97%-6.95M
-15.23%-2.63M
-60.09%-2.28M
---1.43M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Operating cash flow (direct method)
Cash income from operating activities -10.69%4.42M4.95M2,411.67%1.02M19.77%40.54K33.85K
Revenue from customers -----55.34%2.21M--4.95M----2,411.67%1.02M19.77%40.54K--33.85K
Income from government grants ------2.21M--------------------
Cash paid 51.12%-1.13M68.74%-2.3M-5.05%-7.36M-92.21%-7.01M-54.94%-3.65M-54.24%-2.35M-1.53M
Payments to suppliers for goods and services 51.12%-1.13M68.74%-2.3M-5.05%-7.36M-92.21%-7.01M-54.94%-3.65M-54.24%-2.35M---1.53M
Direct interest paid ----200.00%157---157----98.16%-63-634.84%-3.42K---465
Direct interest received 36.90%183.92K24.94%134.35K57.09%107.53K147.60%68.45K-22.63%27.65K-58.18%35.73K--85.44K
Operating cash flow -2,227.35%-941.33K101.92%44.25K66.81%-2.3M-166.85%-6.94M-14.04%-2.6M-62.09%-2.28M---1.41M
Investing cash flow
Cash flow from continuing investing activities -1,885.90%-36.04K-1.82K87.06%-3.87K-1,154.32%-29.88K87.52%-2.38K-19.08K
Net PPE purchase and sale -------1.82K----87.06%-3.87K-1,154.32%-29.88K87.52%-2.38K---19.08K
Net business purchase and sale ---36.04K------------------------
Cash from discontinued investing activities
Investing cash flow -1,885.90%-36.04K---1.82K----87.06%-3.87K-1,154.32%-29.88K87.52%-2.38K---19.08K
Financing cash flow
Cash flow from continuing financing activities 3.29M01,305.79%13.51M-83.80%960.8K5.93M
Net common stock issuance --3.29M------------1,305.79%13.51M-83.80%960.8K--5.93M
Cash from discontinued financing activities
Financing cash flow --3.29M--0--------1,305.79%13.51M-83.80%960.8K--5.93M
Net cash flow
Beginning cash position 0.86%4.95M-31.93%4.91M-49.05%7.22M330.88%14.16M-28.70%3.29M4,336.85%4.61M--103.9K
Current changes in cash 5,347.58%2.31M101.84%42.43K66.83%-2.3M-163.87%-6.95M922.14%10.88M-129.36%-1.32M--4.51M
End cash Position 46.66%7.27M0.86%4.95M-31.93%4.91M-49.05%7.22M330.88%14.16M-28.70%3.29M--4.61M
Free cash from -2,318.34%-941.33K101.84%42.43K66.83%-2.3M-163.97%-6.95M-15.23%-2.63M-60.09%-2.28M---1.43M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More